Oxidized phospholipid dynamics in the early post-infarction period: Effects of PCSK9 inhibition with evolocumab. Atallah M, Harb T, Nasrallah N, Jones SR, et al. Atherosclerosis 2025;409:120469.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Atallah M, Harb T, Nasrallah N, Jones SR, et al. Oxidized phospholipid dynamics in the early post-infarction period: Effects of PCSK9 inhibition with evolocumab. Atherosclerosis 2025;409:120469.
PMID: 40780143